Oncogenic cell cycle start control

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 477, Issue 1-2, 2001, Pages 23-29

  Jinno, Shigeki ^a   Lin, Jie ^a   Yageta, Mika ^a   Okayama, Hiroto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anchorage independent; Hematopoietic cell; Oncogenic stimulation

Indexed keywords

CDK6 KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; CANCER CELL; CATALYSIS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; FIBROBLAST; HEMATOPOIETIC CELL; MUTANT; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL ADHESION; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASES; FIBROBLASTS; HUMANS; ONCOGENES; PROTEIN-SERINE-THREONINE KINASES;

EID: 0035796026     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00092-6     Document Type: Review

References (58)

1. Freedman V.H., Shin S.I. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell. 3:1974;355-359.
2. Cifone M.A. In vitro growth characteristics associated with benign and metastatic variants of tumor cells. Cancer Metastasis Rev. 1:1982;335-347.
3. 1. Gene. Dev. 7:1993;812-821.
4. 1-S transition of the mammallian cell cycle. Mutat. Res. 436:1999;1-9.
5. Sherr C.J. D-type cyclins. Trends Biochem. Sci. 20:1995;187-190.
6. Bates S.L., Bonetta D., MacAllan D., Parry A., Holder A., Dickson C., Peters G. CDK6(PLSTIRE) and CDK4(PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene. 9:1994;71-79.
7. Jinno S., Hung S.C., Okayama H. Cell cycle start from quiescence controlled by tyrosine phosphorylation of Cdk4. Oncogene. 18:1999;565-571.
8. 1 cyclins. Cell. 71:1992;323-334.
9. 1 kinase activity for Cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:1994;2077-2086.
10. 1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
11. Hannon G.J., Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 371:1994;257-261.
12. Guan K.L., Jenkins C.W., Li Y., Nichols M.A., Wu X., O'Keefe C.L., Matera A.G., Xiong Y. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related Cdk6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8:1994;2939-2952.
13. 1 cyclin-dependent kinases. Cell. 75:1993;805-816.
14. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
15. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempest P., Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:1994;59-66.
16. 1 cyclin-CDK protein kinase activity, is related to p21. Cell. 78:1994;67-74.
17. 1 arrest induced by ultraviolet irradiation. Nature. 376:1995;358-362.
18. Iavarone A., Massague J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature. 397:1997;417-422.
19. 1-phase progression. Genes Dev. 13:1999;1501-1512.
20. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., Harlow E. New functional activities for the p21 family of CDK inhibitors. Gene Dev. 11:1997;847-862.
21. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., Sherr C.J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1999;1517-1583.
22. Ewen M.E., Sluss H.K., Sherr C.J., Matsushime H., Kato J., Livingston D.M. Functional interaction of the retinoblastoma protein with mammalian D-type cyclins. Cell. 73:1993;487-497.
23. Kato J., Matsushime H., Hiebert S.W., Ewen M.E., Sherr S.J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase Cdk4. Genes Dev. 7:1993;331-342.
24. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
25. Grana X., Garriga J., Mayol X. Role of the retinoblastoma protein family, pRb, p107 and p130 in the negative control of cell growth. Oncogene. 17:1998;365-383.
26. Dyson N. The regulation of E2F by pRb-family proteins. Genes Dev. 12:1998;2245-2262.
27. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr. Opinion Genet. Dev. 8:1998;28-35.
28. Leatherwood J. Emerging mechanisms of eukaryotic DNA replication initiation. J. Curr. Opinion Cell Biol. 10:1998;742-748.
29. Tada S., Blow J.J. The replication licensing system. Biol. Chem. 379:1998;941-949.
30. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y., Nakayama K. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:1996;707-720.
31. Kiyokawa H., Kineman R.D., Manova-Todorova K.O., Soares V.C., Hoffman E.S., Ono M., Khanam D., Hayday A.C., Frohman L.A., Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 85:1996;721-732.
32. Jiang W., Kahn S.M., Zhou P., Zhang Y.J., Cacace A.M., Infante A.S., Doi S., Santella R.M., Weinstein I.B. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene. 8:1993;3447-3457.
33. 1 phase in rodent fibroblasts. Genes Dev. 7:1993;1559-1571.
34. Swanton C., Mann D.J., Fleckenstein B., Neipel F., Peters G., Jones N. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature. 390:1997;184-187.
35. Masuda A., Kizaka-Kondoh S., Miwatani H., Terada Y., Nojima H., Okayama H. Signal transduction cascade shared by epidermal growth factor and platelet-derived growth factor is a major pathway for oncogenic transformation in NRK cells New. Biol. 4:1992;489-503.
36. Kizaka-Kondoh S., Sato K., Tamura K., Nojima H., Okayama H. Raf1 protein kinase is an integral component of the oncogenic signal cascade shared by epidermal growth factor and platelet-derived growth factor. Mol. Cell. Biol. 12:1992;5078-5086.
37. Kizaka-Kondoh S., Matsuda M., Okayama H. CrkII signals from epidermal growth factor receptor to Ras. Proc. Natl. Acad. Sci. USA. 93:1996;12177-12182.
38. Roberts A.B., Anzano M.A., Lamb L.C., Smith J.M., Sporn M.B. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc. Natl. Acad. Sci. USA. 78:1981;5339-5343.
39. Kume K., Jinno S., Miwatani H., Kizaka-Kondoh S., Terada Y., Nojima H., Okayama H. Oncogenic signal-induced ability to enter S phase in the absence of anchorage is the mechanism for the growth of transformed NRK cells in soft agar. New Biol. 4:1992;504-511.
40. Kizaka-Kondoh S., Okayama H. Raf1 is not a major upstream regulator of MAP kinases in rat fibroblasts. FEBS Lett. 336:1993;255-258.
41. Baskin G., Schenker S., Frosto T., Henderson G. Transforming growth factor β 1 inhibits epidermal growth factor receptor endocytosis and down-regulation in cultured fetal rat hepatocytes. J. Biol. Chem. 266:1991;13238-13242.
42. Hou X., Johnson A.C., Rosner M.R. Induction of epidermal growth factor receptor gene transcription by transforming growth factor β 1: association with loss of protein binding to a negative regulatory element. Cell Growth Differ. 5:1994;801-809.
43. Kizaka-Kondoh S., Akiyama N., Okayama H. Role of TGF-β in EGF-induced transformation of NRK cells is sustaining high level EGF-signaling. FEBS Lett. 466:2000;160-164.
44. Lahaye D.H., Camps M.G., Van Zoelen E.J. Central role of epidermal growth factor (EGF) receptor density in anchorage-independent growth of normal rat kidney cells. FEBS Lett. 446:1999;256-260.
45. Guadagno T.M., Ohtsubo M., Roberts J.M., Assoian R.K. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science. 262:1993;1572-1575.
46. Bartek J., Lukas J., Bartkova J. Perspective: defects in cell cycle control and cancer. J. Pathol. 187:1999;95-99.
47. Jinno S., Hung S.C., Yamamoto H., Lin J., Nagata A., Okayama H. Oncogenic stimulation recruits cyclin-dependent kinase in the cell cycle start in rat fibroblast. Proc. Natl. Acad. Sci. USA. 96:1999;13197-13202.
48. Hu N., Gulley M.L., Kung J.T., Lee E.Y. Retinoblastoma gene deficiency has mitogenic but not tumorigenic effects on erythropoiesis. Cancer Res. 57:1997;4123-4129.
49. 1 control in retinoblastoma gene-deficient cells independently of Cdk4 activity. Mol. Cell. Biol. 15:1995;2600-2611.
50. Corcoran M.M., Mould S.J., Orchard J.A., Ibbotson R.E., Chapman R.M., Boright A.P., Platt C., Tsui L.C., Scherer S.W., Oscier D.G. Dysregulation of cyclin-dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene. 18:1999;6271-6277.
51. Lien H.C., Lin C.W., Huang P.H., Chang M.L., Hsu S.M. Expression of cyclin-dependent kinase 6 (Cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas. Lab. Invest. 80:2000;893-900.
52. Timmermann S., Hinds P.W., Munger K. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. Cell Growth Differ. 8:1997;361-370.
53. Costello J.F., Plass C., Arap W., Chapman V.M., Held W.A., Berger M.S., Su Huang H.J., Cavenee W.K. Cyclin-dependent kinase 6 (Cdk6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res. 57:1997;1250-1254.
54. J. Lin, S. Jinno, H. Okayama, Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence, Oncogene, in press.
55. Tatsuka M., Orita S., kakunaga T. Analysis of cell variants showing differential susceptibilities to radiation- or chemical-induced neoplastic transformation: differences in their responses to growth factors. J. cell Physiol. 139:1989;18-23.
56. Tatsuka M., Mitsui H., Wada M., Nagata A., Nojima H., Okayama H. Elongation factor-1a gene determines susceptibility to transformation. Nature. 359:1992;333-336.
57. Wagner E.F., Hleb M., Hanna N., Sharma S. A pivotal role of cyclinD3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-modiated human B cell proliferation. J. Immunol. 161:1998;1123-1131.
58. Chilosi M., Doglioni C., Yan Z., Lestani M., Menestrina E., Sorio C., Beneditti A., Vinante E., Pizzolo G., Inghirami G. Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am. J. Pathol. 152:1998;209-217.